Utah Medical Products, Inc.
UTMD
$58.72
$0.390.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.45% | -17.79% | -6.12% | -5.91% | -8.06% |
| Total Depreciation and Amortization | -58.54% | -61.05% | -61.28% | -40.64% | 2.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.00% | -2.88% | -324.00% | -498.82% | -6.67% |
| Change in Net Operating Assets | 11.13% | -32.74% | -15.56% | 148.46% | -45.38% |
| Cash from Operations | -24.70% | -43.78% | -23.70% | -6.13% | -8.37% |
| Capital Expenditure | 52.15% | 65.63% | 48.84% | -136.84% | 42.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 52.15% | 64.06% | 111.63% | -136.84% | 42.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 390.00% | 357.14% | -100.00% | 80.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.77% | -1.03% | -1.78% | -1.90% | -1.81% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -375.17% | -611.88% | -279.69% | -16.41% | -0.29% |
| Foreign Exchange rate Adjustments | 223.87% | -137.10% | -1,067.57% | -40.42% | 67.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.36% | -223.79% | -83.96% | -15.92% | 9.22% |
